Cerebrospinal fluid biomarkers in Creutzfeldt-Jakob disease

Clinical Neurology and Neurosurgery

Volumn 107, Issue 5, 2005, Pages 355-360

  Van Everbroeck, B ^a   Boons, J ^a   Cras, P ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

14 3 3 Protein; Amyloid beta; Differential diagnosis; Prion disease; Sporadic CJD; Tau protein; Variant CJD

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; BIOLOGICAL MARKER; NEURON SPECIFIC ENOLASE; PRION PROTEIN; PROTEIN 14 3 3; PROTEIN S 100; TAU PROTEIN;

CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; CREUTZFELDT JAKOB DISEASE; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE DURATION; DISEASE MARKER; GENETIC DISORDER; HUMAN; IATROGENIC DISEASE; PROTEIN DETERMINATION; REVIEW; WESTERN BLOTTING;

14-3-3 PROTEINS; BIOLOGICAL MARKERS; CREUTZFELDT-JAKOB SYNDROME; HUMANS; PRIONS; TAU PROTEINS;

EID: 22144434340     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clineuro.2004.12.002     Document Type: Review

References (57)

1. S.B. Prusiner The prion diseases Brain Pathol 8 1998 499 513
2. B. Van Everbroeck, P. Pals, S. Quoilin, J.J. Martin, and P. Cras The many faces of human prion diseases in Belgium and the world Acta Neurol Belg 101 2001 81 87
3. P. Gambetti, Q.Z. Kong, W.Q. Zou, P. Parchi, and S.G. Chen Sporadic and familial CJD: classification and characterisation Br Med Bull 66 2003 213 239
4. C.J. Gibbs Jr., D.C. Gajdusek, D.M. Asher, M.P. Alpers, E. Beck, and P.M. Daniel Creutzfeldt-Jakob disease (spongiform encephalopathy): transmission to the chimpanzee Science 161 1968 388 389
5. R.G. Will, and W.B. Matthews Evidence for case-to-case transmission of Creutzfeldt-Jakob disease J Neurol Neurosurg Psychiatry 45 1982 235 238
6. C.J.G. Lang, J.G. Heckmann, and B. Neundorfer Creutzfeldt-Jakob disease via dural and corneal transplants J Neurol Sci 160 1998 128 139
7. R.G. Will, J.W. Ironside, M. Zeidler, S.N. Cousens, K. Estibeiro, and A. Alperovitch A new variant of Creutzfeldt-Jakob disease in the UK Lancet 347 1996 921 925
8. A.F. Hill, M. Desbruslais, S. Joiner, K.C.L. Sidle, I. Gowland, and J. Collinge The same prion strain causes vCJD and BSE Nature 389 1997 448 450
9. M.E. Bruce, R.G. Will, J.W. Ironside, I. McConnell, D. Drummond, and A. Suttie Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent Nature 389 1997 498 501
10. P. Pals, B. Van Everbroeck, R. Sciot, C. Godfraind, W. Robberecht, and R. Dom A retrospective study of Creutzfeldt-Jakob disease in Belgium Eur J Epidemiol 15 1999 517 519
11. B. Van Everbroeck, I. Dobbeleir, M. De Waele, P. De Deyn, J.J. Martin, and P. Cras Differential diagnosis of 201 possible Creutzfeldt-Jakob disease patients J Neurol 251 2004 298 304
12. J.E. Olsson Brain and CSF proteins in Creutzfeldt-Jakob disease Eur Neurol 19 1980 85 90
13. A.W. Lemstra, M.T. van Meegen, J.P. Vreyling, P.H. Meijerink, G.H. Jansen, and S. Bulk 14-3-3 testing in diagnosing Creutzfeldt-Jakob disease: a prospective study in 112 patients Neurology 55 2000 514 516
14. M. Vandermeeren, M. Mercken, E. Vanmechelen, J. Six, A. van de Voorde, and J.J. Martin Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay J Neurochem 61 1993 1828 1834
15. A. Aitken, D.B. Collinge, B.P. van Heusden, T. Isobe, P.H. Roseboom, and G. Rosenfeld 14-3-3 Proteins: a highly conserved, widespread family of eukaryotic proteins Trends Biochem Sci 17 1992 498 501
16. T. Ichimura, T. Isobe, T. Okuyama, N. Takahashi, K. Araki, and R. Kuwano Molecular cloning of cDNA coding for brain-specific 14-3-3 protein, a protein kinase-dependent activator of tyrosine and tryptophan hydroxylases Proc Natl Acad Sci USA 85 1988 7084 7088
17. H. Martin, Y. Patel, D. Jones, S. Howell, K. Robinson, and A. Aitken Antibodies against the major brain isoforms of 14-3-3 protein: an antibody specific for the N-acetylated amino-terminus of a protein FEBS Lett 336 1993 189
18. A. Aitken, S. Howell, D. Jones, J. Madrazo, and Y. Patel 14-3-3 alpha and delta are the phosphorylated forms of raf-activating 14-3-3 beta and zeta. In vivo stoichiometric phosphorylation in brain at a Ser-Pro-Glu-Lys MOTIF J Biol Chem 270 1995 5706 5709
19. P.F. Boston, P. Jackson, and R.J. Thompson Human 14-3-3 protein: radioimmunoassay, tissue distribution, and cerebrospinal fluid levels in patients with neurological disorders J Neurochem 38 1982 1475 1482
20. J. Wiltfang, M. Otto, H.C. Baxter, M. Bodemer, P. Steinacker, and E. Bahn Isoform pattern of 14-3-3 proteins in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease J Neurochem 73 1999 2485 2490
21. G. Hsich, K. Kenney, C.J. Gibbs, K.H. Lee, and M.G. Harrington The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies N Engl J Med 335 1996 924 930
22. M.G. Harrington, and C.R. Merril Cerebrospinal fluid protein analysis in diseases of the nervous system J Chromatogr 429 1988 345 358
23. M.G. Harrington, C.R. Merril, D.M. Asher, and D.C. Gajdusek Abnormal proteins in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease N Engl J Med 315 1986 279 283
24. P. Beaudry, P. Cohen, J.P. Brandel, N. Delasnerie-Laupretre, S. Richard, and J.M. Launay 14-3-3 Protein, neuron-specific enolase, and S-100 protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease Dement Geriatr Cogn Disord 10 1999 40 46
25. I. Zerr, M. Bodemer, O. Gefeller, M. Otto, S. Poser, and J. Wiltfang Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease Ann Neurol 43 1998 32 40
26. I. Zerr, M. Pocchiari, S. Collins, J.P. Brandel, J. de Pedro Cuesta, and R.S. Knight Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease Neurology 55 2000 811 815
27. A.J. Green, E.J. Thompson, G.E. Stewart, M. Zeidler, J.M. McKenzie, and M.A. MacLeod Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease J Neurol Neurosurg Psychiatry 70 2001 744 748
28. B. Van Everbroeck, S. Quoilin, J. Boons, J.J. Martin, and P. Cras A prospective study of CSF markers in 250 patients with possible Creutzfeldt-Jakob disease J Neurol Neurosurg Psychiatry 74 2003 1210 1214
29. J. Satoh, M. Yukitake, K. Kurohara, H. Takashima, and Y. Kuroda Detection of the 14-3-3 protein in the cerebrospinal fluid of Japanese multiple sclerosis patients presenting with severe myelitis J Neurol Sci 212 2003 11 20
30. T. Chapman, D.W. McKeel, and J.C. Morris Misleading results with the 14-3-3 assay for the diagnosis of Creutzfeldt-Jakob disease - Reply Neurology 56 2001 986
31. J. Satoh, K. Kurohara, M. Yukitake, and Y. Kuroda The 14-3-3 protein detectable in the cerebrospinal fluid of patients with prion-unrelated neurological diseases is expressed constitutively in neurons and glial cells in culture Eur Neurol 41 1999 216 225
32. L.E.H. Echebarria, A. Saiz, F. Graus, J. Tejada, J.M. Garcia, and B. Clavera Detection of 14-3-3 protein in the CSF of a patient with Hashimoto's encephalopathy Neurology 54 2000 1539 1540
33. K. Kenney, C. Brechtel, H. Takahashi, K. Kurohara, P. Anderson, and C.J. Gibbs Jr. An enzyme-linked immunosorbent assay to quantify 14-3-3 proteins in the cerebrospinal fluid of suspected Creutzfeldt-Jakob disease patients Ann Neurol 48 2000 395 398
34. J. Leuck, K. Peoch, J.L. Laplanche, E. Grabar, W.E. Muller, and H.C. Schroder A novel binding assay for detection of 14-3-3 protein in cerebrospinal fluid from Creutzfeldt-Jakob patients Cell Mol Biol 46 2000 1291 1296
35. K. Peoch, H.C. Schroder, J.L. Laplanche, S. Ramljak, and W.E.G. Muller Determination of 14-3-3 protein levels in cerebrospinal fluid from Creutzfeldt-Jakob patients by a highly sensitive capture assay Neurosci Lett 301 2001 167 170
36. A.J. Green, S. Ramljak, W.E. Muller, R.S. Knight, and H.C. Schroder 14-3-3 in the cerebrospinal fluid of patients with variant and sporadic Creutzfeldt-Jakob disease measured using capture assay able to detect low levels of 14-3-3 protein Neurosci Lett 324 2002 57 60
37. I. Kohira, T. Tsuji, H. Ishizu, Y. Takao, A. Wake, and K. Abe Elevation of neuron-specific enolase in serum and cerebrospinal fluid of early stage Creutzfeldt-Jakob disease Acta Neurol Scand 102 2000 385 387
38. I. Zerr, M. Bodemer, S. Racker, S. Grosche, S. Poser, and H.A. Kretzschmar Cerebrospinal fluid concentration of neuron-specific enolase in diagnosis of Creutzfeldt-Jakob disease Lancet 345 1995 1609 1610
39. S. Kropp, I. Zerr, W.J. Schulz-Schaeffer, C. Riedemann, M. Bodemer, and C. Laske Increase of neuron-specific enolase in patients with Creutzfeldt-Jakob disease Neurosci Lett 261 1999 124 126
40. M. Otto, H. Stein, A. Szudra, I. Zerr, M. Bodemer, and O. Gefeller S-100 protein concentration in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease J Neurol 244 1997 566 570
41. M. Otto, J. Wiltfang, H. Tumani, I. Zerr, M. Lantsch, and J. Kornhuber Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease Neurosci Lett 225 1997 210 212
42. M. Otto, J. Wiltfang, L. Cepek, M. Neumann, B. Mollenhauer, and P. Steinacker Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease Neurology 58 2002 192 197
43. M. Otto, H. Esselmann, W. Schulz-Shaeffer, M. Neumann, A. Schroter, and P. Ratzka Decreased beta-amyloid1-42 in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease Neurology 54 2000 1099 1102
44. B. Van Everbroeck, A.J. Green, P. Pals, J.J. Martin, and P. Cras Decreased levels of amyloid-beta 1-42 in cerebrospinal fluid of Creutzfeldt-Jakob disease patients J Alzheimers Dis 1 1999 419 424
45. J. Bieschke, A. Giese, W. Schulz-Schaeffer, I. Zerr, S. Poser, and M. Eigen Ultrasensitive detection of pathological prion protein aggregates by dual-color scanning for intensely fluorescent targets Proc Natl Acad Sci USA 97 2000 5468 5473
46. G.M. Shaked, Y. Shaked, Z. Kariv Inbal, M. Halimi, I. Avraham, and R. Gabizon A protease-resistant prion protein isoform is present in urine of animals and humans affected with prion diseases J Biol Chem 276 2001 31479 31482
47. N.J. Andrews, C.P. Farrington, H.J.T. Ward, S.N. Cousens, P.G. Smith, and A.M. Molesworth Deaths from variant Creutzfeldt-Jakob disease in the UK Lancet 361 2003 751 752
48. R.G. Will, M. Zeidler, G.E. Stewart, M.A. Macleod, J.W. Ironside, and S.N. Cousens Diagnosis of new variant Creutzfeldt-Jakob disease Ann Neurol 47 2000 575 582
49. M.D. Spencer, R.S.G. Knight, and R.G. Will First hundred cases of variant Creutzfeldt-Jakob disease: retrospective case note review of early psychiatric andneurological features BMJ 324 2002 1479 1482
50. M. Zeidler, G.E. Stewart, C.R. Barraclough, D.E. Bateman, D. Bates, and D.J. Burn New variant Creutzfeldt-Jakob disease: neurological features and diagnostic tests Lancet 350 1997 903 907
51. J. Collinge, K.C. Sidle, J. Meads, J. Ironside, and A.F. Hill Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD Nature 383 1996 685 690
52. S.B. Prusiner, and K.K. Hsiao Human prion diseases Ann Neurol 35 1994 385 395
53. L.G. Goldfarb, P. Brown, E. Mitrova, L. Cervenakova, L. Goldin, and A.D. Korczyn Creutzfeldt-Jacob disease associated with the PRNP codon 200Lys mutation: an analysis of 45 families Eur J Epidemiol 7 1991 477 486
54. P. Brown, F. Cathala, R. Labauge, M. Pages, J.C. Alary, and H. Baron Epidemiologic implications of Creutzfeldt-Jakob disease in a 19-year-old girl Eur J Epidemiol 1 1985 42 47
55. J. Collinge, and M.S. Palmer Human prion diseases Baillieres Clin Neurol 3 1994 241 247
56. H. Rosenmann, Z. Meiner, E. Kahana, M. Halimi, E. Lenetsky, and O. Abramsky Detection of 14-3-3 protein in the CSF of genetic Creutzfeldt-Jakob disease Neurology 49 1997 593 595
57. S. Collins, A. Boyd, A. Fletcher, M. Gonzales, C.A. McLean, and K. Byron Creutzfeldt-Jakob disease: diagnostic utility of 14-3-3 protein immunodetection in cerebrospinal fluid J Clin Neurosci 7 2000 203 208